DESI-MS-Based Analysis of Drug Distribution in Human Renal Cystic Tissue Using the Chorioallantoic Membrane (CAM) as a 3D In Vivo Model
Antonia Hehemann, Jan Schueler, Simon Heckscher, Verena Groß, Matthias MayiD, Barbara Nuebel, Bernd Wullich, Bjoern BuchholziD, Jens M. WerneriD, Jonathan JantschiD, Wolfram GronwaldiD, Zoltán TakátsiD, Peter Josef OefneriD, Katharina Maria SchmidtiD, Silke HaerteisiD, Katja DettmeriD
Abstract
The chorioallantoic membrane (CAM) model represents a promising three-dimensional in vivo platform for preclinical drug testing in human tissues. In this study, we investigated whether the tissue penetration and distribution of benzbromarone, a known inhibitor of the Ca2+ activated chloride channel TMEM16A and potential therapeutic agent for autosomal dominant polycystic kidney disease (ADPKD), can be successfully visualized in human renal cyst tissue cultured on the CAM. To this end, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) combined with an ultrahigh-resolution time-of-flight mass spectrometer was employed. We achieved spatially resolved molecular mapping of endogenous metabolites and lipids as well as the applied compound. MSI enabled clear differentiation between CAM and cystic tissue based on their distinct lipid profiles. Benzbromarone was reproducibly detected in the cyst specimens and exhibited selective accumulation along the cyst epithelium, which is considered the principal site of action. These observations were complemented by multivariate analyses including Uniform Manifold Approximation and Projection (UMAP), and sparse multinomial logistic zero-sum classification. The data-driven approach confirmed molecular differences between tissue types and allowed accurate classification of drug-treated and untreated regions. This study demonstrates that topically applied benzbromarone penetrates human renal cyst tissue in the CAM model and localizes to pharmacologically relevant tissue regions, notably the location of the Ca2+ activated chloride channel TMEM16A in the epithelial lining. The integration of high-resolution DESI-MSI with advanced statistical analysis provides a robust and label-free method to study drug distribution in human tissue grafts. Our findings contribute to the advancement of translational research in analytical chemistry and pharmacology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combination siRNA delivery as a therapeutic strategy for ADPKD
Joshua Giblin, Isabella Suzuki, … Eun Ji Chung·bioRxiv·Jul 21, 2026
- The Lonidamine Derivative H2-Gamendazole Reduces Cyst Formation in Polycystic Kidney Disease
S. V. Sundar, X. Zhou, … J. P. Calvet·bioRxiv·Sep 9, 2020
- Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.
Eduardo Guadarrama, Carlos G. Vanoye, Paul G. DeCaen·bioRxiv·Jan 13, 2025
- Dibenzoylmethane, a novel β-diketone pore blocker of large-conductance calcium-activated potassium channel
Piotr Koprowski, Przemysław Miszta, … Michał Tomczyk·bioRxiv·Apr 28, 2026
- Bridging the gap between in silico and in vivo: modeling opioid disposition in a kidney proximal tubule microphysiological system
T. Imaoka, W. Huang, … E. J. Kelly·bioRxiv·Dec 4, 2020
- Distinct modulation of calcium-activated chloride channel TMEM16A by a novel drug-binding site